Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

DocStation and CPESNŽ USA Enable Pharmacies Through Medical Billing Collaboration


Dynamic commitment to local, community-based pharmacies will simplify the connection with approved medical billing partners and continue to drive pharmacy practice forward with new medical billing and reimbursement intelligence

AUSTIN, Texas, March 13, 2024 /PRNewswire-PRWeb/ -- DocStation, a pioneer in pharmacy software innovations such as automated billing, is partnering with CPESNŽ USA, a network of high-performing, clinically-integrated local pharmacies, to facilitate pharmacies' entry into the medical billing arena.

We're excited to formally join Troy and team on this journey by empowering their members with technology that makes it easy to stand up a clinical practice and get paid for services.

DocStation and CPESNŽ USA are working together to provide guidance and education that enables pharmacies to get paid for services in provider status states like Minnesota, Texas, California, New York, Pennsylvania, Ohio, Tennessee, Washington and many more.

"On behalf of the leadership team at CPESNŽ USA, I'd like to express our collective enthusiasm about the collaboration with DocStation and their distinctive, datashare-compliant medical billing platform," said Troy Trygstad, PharmD, MBA, PhD, Executive Director of CPESNŽ USA. "The CPESN network of 3,500 community-based pharmacies has consistently led in uniting payers, pharmacies, and communities to enhance local health services. We anticipate the integration with DocStation will help to empower our pharmacies in initiating clinical service programs with efficient reimbursement, a crucial step in their transformation into essential community healthcare centers."

Pharmacists' roles expanded during the pandemic, leading to an increase in clinical services offered to patients. These services must also be billed to support the staff who offer such services. Together DocStation and CPESNŽ USA are working to provide solutions that allow pharmacists to submit medical claims for clinical services they provide to their patients, reducing the amount of time spent on paperwork and other administrative tasks.

"CPESNŽ USA is leading the provider status movement, and their members are among the most innovative entrepreneurs in our industry," said Samm Anderegg, PharmD, CEO at DocStation. "We're excited to formally join Troy and team on this journey by empowering their members with technology that makes it easy to stand up a clinical practice and get paid for services."

CPESNŽ USA and DocStation are working together to master the payer landscape and streamline medical billing. Both companies view the collaborative relationship as elevating their commitment to transparency and supporting their mutual clients.

"Medical billing for pharmacists can pose difficult scenarios in the contrast of scope of practice for a pharmacist against the scope of license allowed by the state that grants the license," Director of CPESN Medical Billing Supports, Travis Wolff, reports. "The transparency created in the datashare compliant collaboration between CPESN and DocStation is an ongoing commitment to the integrity of the pharmacist as we move our profession to new horizons, navigating very specific guidance in state laws and payer preferences."

About DocStation

DocStation is a leading provider of innovative pharmacy software solutions, dedicated to empowering community pharmacies to deliver exceptional patient care. With a focus on leveraging technology to optimize pharmacy operations, DocStation offers a range of advanced features and functionalities that streamline workflows, enhance revenue generation, and improve patient outcomes.

Contact:

Kendall Stempel

Director of Marketing

[email protected]

About CPESNŽ USA

CPESNŽ USA is the Community Pharmacy Enhanced Services Network. It is a clinically integrated network of community pharmacies that coordinates patient care with broader care teams to provide medication optimization activities and enhanced services for high-risk patients.

Contact:

Jay Williams

Director

[email protected]

Media Contact

Mary Elkordy, Elkordy Global Strategies, 1 3479062514, [email protected] 

SOURCE DocStation


These press releases may also interest you

at 08:15
Masimo Corporation ("Masimo" or the "Company") today issued a letter to stockholders in connection with the Company's 2024 Annual Meeting of Stockholders. The letter highlights the fierce independence and deep medtech experience of nominee...

at 08:15
KaliVir Immunotherapeutics, Inc., a biotech company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs, today announced that the FDA has cleared the Investigational New Drug (IND) application for the STEALTH-001 study...

at 08:10
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic disease, today announced the closing of its previously announced $11.8 million private placement to accredited...

at 08:10
Kashiv BioSciences, LLC ("Kashiv" or the "Company") today announced that it has entered into an exclusive licensing agreement for ADL018, a proposed biosimilar to omalizumab referencing XOLAIRŽ, with Amneal Pharmaceuticals, Inc. ("Amneal") for the...

at 08:10
N-Power Medicine, a company reinventing the clinical trial process, announced the initial close of a Series B funding round, raising its total funding to date to $72 Million. The Series B round is led by Merck Global Health Innovation Fund, with...

at 08:07
NRx Pharmaceuticals, Inc. ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that the Company posted a new Shareholder Update Letter on its website NRx Shareholder Update and further invites...



News published on and distributed by: